References

1. Bleyer WA O'Leary M, Barr R, Ries LAG (eds) (2006) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, including SEER Incidence and Survival, 1975-2000. National Cancer Institute, NIH Pub. No. 06-5767, Bethesda MD; also available at www.seer.cancer.gov/publications

2. Brown J, Shvartsman HS, Deavers MT, et al (2004b) The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol 22:3517-3523

3. Raney RB Jr, Sinclair L, Uri A, et al (1987) Malignant ovarian tumors in children and adolescents. Cancer 59:1214-1220

4. Bernstein L, Smith MA, Liu L, et al (1999) Germ cell, trophoblastic and other gonadal neoplasms ICCC X. In: Ries AG, Smith MA, Gurney JG, et al (eds) Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. NIH Pub. No. 99-4649. Bethesda: National Cancer Institute, SEER Program, pp 139-147

5. Serov SF, Scully RE, Robin IH (1973) Histological Typing of Ovarian Tumors: International Histological Classification of Tumors, World Health Organization, Geneva, No. 9

6. Young JL Jr, Wu XC, Roffers SD, et al (2003) Ovarian cancer in children and young adults in the United States, 1992-1997. Cancer 97: 2694-2700

7. Morowitz M, Huff D, von Allmen D (2003) Epithelial ovarian tumors in children: a retrospective analysis. J Pediatr Surg 38:331-335

8. Fotiou SK (1997) Ovarian malignancies in adolescence. Ann NY Acad Sci 816:338-346

9. Williams SD, Gershenson DM, Horowitz CJ, et al (2000) Ovarian GCT. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and Practice of Gynecologic Oncology (3rd edn). Lippincott Williams and Wilkins, Philadelphia, pp 1059-1073

10. Emans SJH, Laufer MF, Goldstein DP (eds) (1998) Pediatric and Adolescent Gynecology (4th edn). Lippincott-Raven, Philadelphia, p 562

11. Cushing B, Giller R, Cullen JW, et al (2004) Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric inter-group study - Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol 22:26912700

12. Rogers PC, Olson TA, Cullen JW, et al (2004) Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a Pediatric Intergroup Study - Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol 22:3563-3569

13. Castedo SM, de Jong B, Oosterhuis JW, et al (1989) Chromosomal changes in human primary testicular nonseminomatous germ cell tumors. Cancer Res 49:5696-5701

14. Riopel MA, Spellerberg A, Griffin CA, et al (1998) Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization. Cancer Res 58:31053110

15. Samaniego F, Rodriguez E, Houldsworth J, et al (1990) Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification. Genes Chromosomes Cancer 1:289-300

16. Bussey KJ, Lawce HJ, Olson SB, et al (1999) Chromosome abnormalities of eighty-one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences - a Children's Cancer Group study. Genes Chromosomes Cancer 25:134-146

17. Perlman EJ, Hu J, Ho D, et al (2000) Genetic analysis of childhood endodermal sinus tumors by comparative genomic hybridization. J Pediatr Hematol Oncol 22:100-105

18. Schneider DT, Schuster AE, Fritsch MK, et al (2001) Multipotent imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Res 61:7268-7276

19. Schneider DT, Schuster AE, Fritsch MK, et al (2001) Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Klin Padiatr 213:204-211

20. Koonings PP, Campbell K, Mishell DR Jr, et al (1989) Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 74:921-926

21. Duska LR, Chang Y, Flynn CE (1999) Epithelial ovarian cancer in the reproductive age group. Cancer 85:26232629

22. Hogg R, Friedlander M (2004) Biology of epithelial ovarian cancer: implications for screening women at high genetic risk. J Clin Oncol 22:1315-1327

23. Taylor HC (1929) Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet 48:204-230

24. Lawrence WD (1995) The borderland between benign and malignant surface epithelial ovarian tumors. Current controversy over the nature and nomenclature of 'borderline' ovarian tumors. Cancer 76:2138-2142

25. Katsube Y, Berg JW, Silverberg SG (1982) Epidemio-logic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area 1 July-31 December 1969 and 1 July-31 December 1979. Int J Gynecol Pathol 1:3-16

26. Scully RE (1982) Common epithelial tumors of borderline malignancy. Bull Cancer (Paris) 69:228-238

27. Kohlberger PD, Kieback DG, Mian C, et al (1997) Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67. J Soc Gynecol Invest 4:262-264

28. Gribbon, M, Ein SH, Mancer K (1992) Pediatric malignant ovarian tumors: a 43-year review. J Pediatr Surg 27:480-484

29. Lacson AG, Gillis DA, Shawwa A (1988) Malignant mixed germ-cell-sex cord-stromal tumors of the ovary associated with isosexual precocious puberty. Cancer 61:2122-2133

30. Scully RE (1970) Sex cord tumor with annular tubules: a distinctive ovarian tumor of the Peutz-Jeghers syndrome. Cancer 25:1107-1121

31. Young RH, Welch WR, Dickersin GR, Scully RE (1982) Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 50:1384-1402

32. Berek JS, Hacker NF (eds) (1994) Nonepithelial ovarian and fallopian tube cancers. In: Practical Gynecologic Oncology (2nd edn). Williams and Wilkins, Baltimore, pp 380-381

33. Tewari K, Cappuccini F, Disaia PJ, et al (2000) Malignant germ cell tumors of the ovary. Obstet Gynecol 95:128-133

34. Bjorkholm E, Silfversward C (1981) Prognostic factors in granulosa-cell tumors. Gynecol Oncol 11:261-274

35. Vergote I, De Brabanter J, Fyles A, et al (2001) Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357:176-182

36. Billmire D, Vinocur C, Rescorla F, et al (2004) Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 39:424-429

37. Abu-Rustum NR, Aghajanian C (1998) Management of malignant germ cell tumors of the ovary. Semin Oncol 25:235-242

38. Gershenson DM (1994) Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gyne-col Oncol 55:S62-72

39. Cannistra SA (1993) Cancer of the ovary. N Engl J Med 329:1550-1559

40. International Federation of Gynecology and Obstetrics (1987) Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 156:263-264

41. Baranzelli MC, Flamant F, De Lumley L, et al (1993) Treatment of non-metastatic, non-seminomatous malignant germ-cell tumours in childhood: experience of the "Societe Francaise d'Ongologie Pediatrique" MGCT 1985-1989 study. Med Pediatr Oncol 21:395401

42. Gobel U, Calaminus G, Haas RJ, et al (1989) Combination chemotherapy in malignant non-seminomatous germ-cell tumors: results of a cooperative study of the

German Society of Pediatric Oncology (MAKEI 83). Cancer Chemother Pharmacol 24:34-39

43. Mann JR, Raafat T, Robinson K, et al (2000) The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomy-cin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol. 18:3809-3818

44. Gershenson DM (1994) Editorial: The obsolescence of second-look laparotomy in the management of malignant ovarian germ cell tumors. Gynecol Oncol 52:283285

45. Disaia PJ, Creasman WT (eds) (2002) Germ cell, stro-mal, and other ovarian tumors. In: Clinical Gynecologic Oncology (6th edn). Mosby, St. Louis, MO, pp 362-363

46. Brewer M, Gershenson DM, Herzog CE, et al (1999) Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 17:26702675

47. Schumer ST, Cannistra SA (2003) Granulosa cell tumor of the ovary. J Clin Oncol 21:1180-1189

48. Pfleiderer A (1993) Therapy of ovarian malignant germ cell tumors and granulosa tumors. Int J Gynecol Pathol 12:162-165

49. Colombo N, Chiari S, Maggioni A, et al (1994) Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol 55:S47-S51

50. Le T, Krepart GV, Lotocki RJ, Heywood MS (1999) Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly? Gynecol Oncol 74:252-254

51. Hoskins WJ (1994) Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol 55:S91-96

52. Lin PS, Gershenson DM, Bevers MW, et al (1999) The current status of surgical staging of ovarian serous borderline tumors. Cancer 85:905-911

53. Yazigi R, Sandstad J, Munoz AK (1988) Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol 31:402-408

54. Gershenson DM, Silva EG, Levy L, et al (1998) Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 82:1096-1103

55. Williams S, Blessing JA, Liao S-Y, et al (1994) Adjuvant therapy of ovarian GCT with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 12:701-706

56. Marina NM, Cushing B, Giller R, et al (1999) Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol 17:2137-2143

57. Dark GG, Bower M, Newlands ES, et al (1997) Surveillance policy for stage I ovarian germ cell tumors. J Clin Oncol 15:620-624

Gobel U, Calaminus G, Haas RJ, et al (2000) Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 11:263-271 Gershenson DM, Copeland LJ, del Junco, et al (1986) Second-look laparotomy in the management of malignant germ cell tumors of the ovary. Cancer 67:789-793 Munkarah A, Gershenson DM, Levenback C, et al (1994) Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol 55:217-223 Homesley HD, Bundy BN, Hurteau JA, et al (1999) Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol 72:131-137

Brown J, Shvartsman HS, Deavers MT, et al (2004) Tax-ane-based chemotherapy compared with bleomycin, etoposide, and cisplatin for the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 92:402 Fishman A, Kudelka AP, Tresukosol D, et al (1996) Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med 41:393396

Young RH, Scully RE (1984) Ovarian Sertoli cell tumors: a report of 10 cases. Int J Gynecol Pathol 2:349363

Gershenson DM, Morris M, Burke TW, et al (1996) Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etopo-side, and cisplatin. Obstet Gynecol 87:527-531 Srivatsa PJ, Keeney GL, Podratz KC (1994) Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome. Gynecol Oncol 53:256264

Gershenson DM, Copeland LJ, Kavanagh JJ, et al (1987) Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 70:765-769

Hartmann LC, Young RH, Podratz KC. (2000) Ovarian sex cord-stromal tumors. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and Practice of Gynecologic Oncology (3rd edn). Lippincott Williams and Wilkins, Philadelphia, pp 1075-1097

69. Deavers MT, Gershenson DM, Tortolero-Luna G, et al (2002) Micropapillary and cribiform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases. Am J Surg Pathol 26:1129-1141

70. Kurman RJ, Norris HJ (1976) Endodermal sinus tumor of the ovary: A clinical and pathologic analysis of 71 cases. Cancer 38:2404-2419

71. Marina N, Fontanesi J, Jun L, et al (1992) Treatment of childhood germ cell tumors: review of the St. Jude experience from 1979-1988. Cancer 70:2568-2575

72. Susnerwala SS, Pande SC, Shrivastava SK, Dinshaw KA (1991) Dysgerminoma of the ovary: review of 27 cases. J Surg Oncol 46:43-47

73. Gershenson DM, Morris M, Cangir A, et al (1990) Treatment of malignant GCT of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 8:715-720

74. La Polla JP, Brenda J, Vigliotti AP, Anderson B (1987) Dysgerminoma of the ovary. Obstet Gynecol 69:859-864

75. Baranzelli MC, Bouffet E, Quintana E, et al (2000) Non-seminomatous ovarian germ cell tumours in children. Eur J Cancer 36:376-383

76. Murphy BA, Motzer RJ, Mazumdar M, et al (1994) Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy. Cancer 73:2520-2526

77. Schneider DT, Janig M, Calaminus, et al (2003) Ovarian sex-cord stromal tumors - a clinicopathological study of 72 cases from the Kiel Pediatric Tumor Registry. Virchows Arch 443:549-560

78. Tsai JY, Saigo PE, Brown C, La Quaglia MP (2001) Diagnosis, pathology, staging, treatment, and outcome of epithelial ovarian neoplasia in patients age < 21 years. Cancer 91:2065-2070

79. Demeter A, Csapo Z, Szantho A, et al (2002) A retrospective study of 27 ovarian tumors of low malignant potential. Eur J Gynaecol Oncol XXIII:415-418

80. DeCherney AH, Nathan L (2003) Current Obstetric and Gynecologic Diagnosis and Treatment (9th edn). Lange Medical Books/McGraw-Hill, New York, p 612

81. Plante M (2000) Fertility preservation in the management of gynecologic cancers. Curr Opin Oncol 12:497507

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment